Navigation Links
Watson Confirms JALYN™ Patent Challenge
Date:7/22/2011

PARSIPPANY, N.J., July 22, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market  dutasteride and tamsulosin hydrochloride capsules. Watson's dutasteride and tamsulosin hydrochloride capsules are a generic version of GlaxoSmithKline's JALYN™. JALYN™ capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)

GlaxoSmithKline filed suit against Watson on July 21, 2011 in the United States District Court for the District of Delaware seeking to prevent Watson from commercializing its product prior to the expiration of U.S. Patent No. 5,565,467. GlaxoSmithKline's lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Watson's ANDA until December 30, 2013, or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities.  

For the twelve months ending May 31, 2011, JALYN™ capsules had total U.S. sales of over $30 million according to IMS Health data.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a leading integrated global pharmaceutical company. The Company is engaged in the development and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web s
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit
2. Watson Confirms Vyvanse® Patent Challenge
3. Watson to Host Conference Call and Webcast to Discuss Second Quarter 2011 Earnings
4. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
5. Watson to Present at 2011 Wells Fargo Securities Healthcare Conference
6. Watson Confirms AVODART(R) Patent Challenge
7. Watson Confirms Court Decision Rejecting Tevas Motion to Prevent Launch of Generic SEASONIQUE®
8. Watsons Nabumetone Tablets Receive FDA Approval
9. Watson Confirms Pataday™ Patent Challenge
10. Watson Confirms Viagra® Patent Challenge
11. Watson to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ReportsnReports.com adds Global Medical ... forecasts as well as Global Medical Simulation Market ... collection of its library. Complete 2015 ... spread across 164 pages, talking about 7 major ... is now available at http://www.reportsnreports.com/reports/407046-global-medical-simulation-industry-report-2015.html . ...
(Date:8/3/2015)... , Aug. 3, 2015 OmniSeq, LLC ... Institute to the OmniSeq SM Genomic Network.  ... Cancer Institute (RPCI) and announced it was making ... a physician-driven, collaborative approach to genomic diagnostics that ... Cancer Institute is a rapidly expanding, multidisciplinary cancer ...
(Date:8/3/2015)... Aug. 3, 2015 Ortho Clinical Diagnostics (OCD) ... named Chief Corporate Brand and Communications Officer, effective immediately. ... team, Bouryal will lead the company,s worldwide corporate brand ... transition to an independent company by adding sites in ... and Chief Executive Officer Dr. Martin Madaus . ...
Breaking Medicine Technology:Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3Ortho Clinical Diagnostics Appoints Kristie Bouryal Chief Corporate Brand and Communications Officer 2
(Date:8/4/2015)... ... August 04, 2015 , ... Many men are confused ... subject, Renew Man™ is standing up as a voice of authority for men seeking ... healthy aging industry with special experience and expertise in the safe and effective treatment ...
(Date:8/4/2015)... ... 2015 , ... Buckeye Health Plan is reminding parents to ... covered for members under the Healthchek program . , “Many schools have ... immunizations may not be allowed to attend when school begins in August,” said ...
(Date:8/4/2015)... ... August 04, 2015 , ... SanusEO, the healthcare industry innovator ... executive leadership team as Senior Vice President of Sales and Marketing. Mr. McCalley ... global markets with a special emphasis on the healthcare industry. , Today, patients ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... T.E.N., an ... for vendor participating in The ISE® Lions’ Den and Jungle Lounge 2015, which will ... in Las Vegas. , During the event, eight emerging security vendors, known as “Gazelles,” ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... finds the North America IT reseller channel will grow at least 6 percent ... of their 2014 pace and greater than their OEM/vendor partners. , The ...
Breaking Medicine News(10 mins):Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3
... Merck is in trouble again. The Federal Drug Administration of U.S ... was pulled out of the market due to safety reasons. ... same class of drugs as Vioxx ,was voted out 20-1 ... Vioxx from the market in September 2004 after research showed that ...
... can be increasingly used to improve patient care. In a recent ... around 2,250 babies in US alone who succumb to sudden infant ... assistant at the University of Texas has come up with a ... , ,Hung Cao, along with his friends developed a device ...
... Fiorillo noticed that her daughter Bianca could not seem to ... She seemed slower at doing things compared to the other ... on diagnoses it was found that she has CMT, Charcot-Marie-Tooth ... and her brother Tony too suffered from it. ...
... therapy for coronary artery disease is four times more likely ... same medical history. ,Historically, studies have shown ... men, but it has remained unclear how much less effective ... pharmacist and adjunct clinical instructor at the University of Michigan ...
... A former official of the Mets, a leading baseball team ... federal court in San Francisco to distributing// performance-enhancing drugs to ... a decade. ,Kirk Radomski, 37, who had worked ... admitted to selling banned drugs, including anabolic steroids, amphetamines and ...
... may be as important to your health as the food ... toxins that might soon become// as important a risk factor ... ,This class of toxins, called advanced glycation end ... of grilled, fried, or broiled animal products, such as meats ...
Cached Medicine News:Health News:Arcoxia Slammed –Nothing Better Than Vioxx Says FD 2Health News:RFID Use can Avoid Sudden Infant Death Syndrome 2Health News:Cure for CMT 2Health News:Aspirin Therapy for Heart Disease Found More Effective for Men Than Women 2Health News:Aspirin Therapy for Heart Disease Found More Effective for Men Than Women 3Health News:Former Official Confesses He Had Sold Steroids to Leading Baseball Players 2Health News:Food Preparation may Play a Bigger Role in Chronic Disease 2Health News:Food Preparation may Play a Bigger Role in Chronic Disease 3Health News:Food Preparation may Play a Bigger Role in Chronic Disease 4
... adjusted for perfect focus where it's needed ... This, along with Keeler's wide angle light ... the patient's pupil size, you will see ... Lithium-ion technology provides a longer life battery ...
... ophthalmoscopes are individually adjusted for perfect focus ... not on paper. This, along with Keeler's ... ensures that whatever the patient's pupil size, ... field of view. Lithium-ion technology provides a ...
The Beta 200S combines Heine's patented aspherical optics (U.S. Pat. 4.963.014) and a single-step Rekoss disk with a range of 36 to +38 dpt. to provide perfectly-focused images even in cases of high ...
A full function instrument at an economical price....
Medicine Products: